196 related articles for article (PubMed ID: 34803166)
21. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
Elife; 2016 Apr; 5():. PubMed ID: 27070462
[TBL] [Abstract][Full Text] [Related]
22. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
Dauch D; Rudalska R; Cossa G; Nault JC; Kang TW; Wuestefeld T; Hohmeyer A; Imbeaud S; Yevsa T; Hoenicke L; Pantsar T; Bozko P; Malek NP; Longerich T; Laufer S; Poso A; Zucman-Rossi J; Eilers M; Zender L
Nat Med; 2016 Jul; 22(7):744-53. PubMed ID: 27213815
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
24. Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation.
Soung do Y; Dong Y; Wang Y; Zuscik MJ; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2007 Aug; 22(8):1260-70. PubMed ID: 17488194
[TBL] [Abstract][Full Text] [Related]
25. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
26. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
Ho JS; Ma W; Mao DY; Benchimol S
Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
[TBL] [Abstract][Full Text] [Related]
27. p53 inhibits the upregulation of sirtuin 1 expression induced by c-Myc.
Yuan F; Liu L; Lei Y; Tang P
Oncol Lett; 2017 Oct; 14(4):4396-4402. PubMed ID: 28943955
[TBL] [Abstract][Full Text] [Related]
28. High-level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome.
Gao L; Saeed A; Golem S; Zhang D; Woodroof J; McGuirk J; Ganguly S; Abhyankar S; Lin TL; Cui W
Int J Lab Hematol; 2021 Feb; 43(1):99-109. PubMed ID: 32812335
[TBL] [Abstract][Full Text] [Related]
29. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
Reisman D; Elkind NB; Roy B; Beamon J; Rotter V
Cell Growth Differ; 1993 Feb; 4(2):57-65. PubMed ID: 8494784
[TBL] [Abstract][Full Text] [Related]
30. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
31. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
[TBL] [Abstract][Full Text] [Related]
32. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
33. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.
Ta VB; de Bruijn MJ; ter Brugge PJ; van Hamburg JP; Diepstraten HJ; van Loo PF; Kersseboom R; Hendriks RW
Blood; 2010 Feb; 115(7):1385-93. PubMed ID: 20008789
[TBL] [Abstract][Full Text] [Related]
35. Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the
Cohen CJ; Davidson C; Selmi C; Bowness P; Knight JC; Wordsworth BP; Vecellio M
Front Genet; 2021; 12():741867. PubMed ID: 35069677
[No Abstract] [Full Text] [Related]
36. MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.
Akita H; Marquardt JU; Durkin ME; Kitade M; Seo D; Conner EA; Andersen JB; Factor VM; Thorgeirsson SS
Cancer Res; 2014 Oct; 74(20):5903-13. PubMed ID: 25189530
[TBL] [Abstract][Full Text] [Related]
37. p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.
Olivero CE; Martínez-Terroba E; Zimmer J; Liao C; Tesfaye E; Hooshdaran N; Schofield JA; Bendor J; Fang D; Simon MD; Zamudio JR; Dimitrova N
Mol Cell; 2020 Feb; 77(4):761-774.e8. PubMed ID: 31973890
[TBL] [Abstract][Full Text] [Related]
38. [Effect of P53 Expression on Prognosis of Patients with Double Expressor Lymphoma].
Ding X; Hou SL; Li YQ; Li X; Li L; Lian K; Wang GG; Wu XB; Zhang ZH; Liu H; Wang YQ; Zhang QH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1504-1514. PubMed ID: 31607305
[TBL] [Abstract][Full Text] [Related]
39. Decoding the Role of Epigenetics in Breast Cancer Using Formal Modeling and Machine-Learning Methods.
Asim A; Kiani YS; Saeed MT; Jabeen I
Front Mol Biosci; 2022; 9():882738. PubMed ID: 35898303
[TBL] [Abstract][Full Text] [Related]
40. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
